FHIRsmith: CodeSystem/CodeSystem-sact-esmo-mcbs-evaluation-form.json

FHIR IG analytics

Package	hl7.org.nz.fhir.ig.cca
Resource Type	CodeSystem
Id	CodeSystem-sact-esmo-mcbs-evaluation-form.json
FHIR Version	R4
Source	https://build.fhir.org/ig/HL7NZ/cca/CodeSystem-sact-esmo-mcbs-evaluation-form.html
URL	https://standards.digital.health.nz/ns/sact-esmo-mcbs-evaluation-form
Version	0.1.0
Status	active
Date	2026-05-21T02:29:02+00:00
Name	EsmoMcbsEvaluationForm
Title	ESMO-MCBS Evaluation Form
Realm	nz
Authority	hl7
Description	The evaluation forms used in the ESMO Magnitude of Clinical Benefit Scale
Content	complete

Resources that use this resource

ValueSet
hl7.org.nz.fhir.ig.cca#current	sact-esmo-mcbs-evaluation-form	ESMO-MCBS Evaluation Form

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: CodeSystem sact-esmo-mcbs-evaluation-form

This code system https://standards.digital.health.nz/ns/sact-esmo-mcbs-evaluation-form defines the following codes:

Code	Display
ST-1a	Evaluation Form 1a: For RCTs evaluating new approaches to adjuvant therapy or new potentially curative therapies
ST-1b	Evaluation Form 1b: For single arm de-escalation studies in the adjuvant setting
ST-2a	Evaluation Form 2a: For therapies that are not likely to be curative with primary endpoint of OS
ST-2b	Evaluation Form 2b: For therapies that are not likely to be curative with primary endpoint PFS
ST-2c	Evaluation Form 2c: For therapies that are not likely to be curative with primary endpoint other than OS or PFS or equivalent (non-inferiority) studies
ST-3	Evaluation Form 3: For single-arm studies in orphan diseases and for diseases with high unmet need when primary outcome is PFS or ORR
HM-1a	Evaluation Form 1a: For RCTs evaluating new approaches to new potentially curative therapies
HM-1b	Evaluation Form 1b: For single arm therapies with curative intent and de-escalation studies
HM-2a	Evaluation Form 2a: For therapies that are not likely to be curative with primary endpoint of OS
HM-2b	Evaluation Form 2b: For therapies that are not likely to be curative with primary endpoint PFS
HM-2c	Evaluation Form 2c: For therapies that are not likely to be curative with primary endpoint other than OS or PFS or equivalent (non-inferiority) studies
HM-3	Evaluation Form 3: For single-arm studies in orphan diseases and for diseases with high unmet need when primary outcome is PFS or ORR

Source1

{
  "resourceType": "CodeSystem",
  "id": "sact-esmo-mcbs-evaluation-form",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "https://standards.digital.health.nz/ns/sact-esmo-mcbs-evaluation-form",
  "version": "0.1.0",
  "name": "EsmoMcbsEvaluationForm",
  "title": "ESMO-MCBS Evaluation Form",
  "status": "active",
  "date": "2026-05-21T02:29:02+00:00",
  "publisher": "Te Aho o Te Kahu, Cancer Control Agency",
  "description": "The evaluation forms used in the ESMO Magnitude of Clinical Benefit Scale",
  "content": "complete",
  "count": 12,
  "concept": [
    {
      "code": "ST-1a",
      "display": "Evaluation Form 1a: For RCTs evaluating new approaches to adjuvant therapy or new potentially curative therapies"
    },
    {
      "code": "ST-1b",
      "display": "Evaluation Form 1b: For single arm de-escalation studies in the adjuvant setting"
    },
    {
      "code": "ST-2a",
      "display": "Evaluation Form 2a: For therapies that are not likely to be curative with primary endpoint of OS"
    },
    {
      "code": "ST-2b",
      "display": "Evaluation Form 2b: For therapies that are not likely to be curative with primary endpoint PFS"
    },
    {
      "code": "ST-2c",
      "display": "Evaluation Form 2c: For therapies that are not likely to be curative with primary endpoint other than OS or PFS or equivalent (non-inferiority) studies"
    },
    {
      "code": "ST-3",
      "display": "Evaluation Form 3: For single-arm studies in orphan diseases and for diseases with high unmet need when primary outcome is PFS or ORR"
    },
    {
      "code": "HM-1a",
      "display": "Evaluation Form 1a: For RCTs evaluating new approaches to new potentially curative therapies"
    },
    {
      "code": "HM-1b",
      "display": "Evaluation Form 1b: For single arm therapies with curative intent and de-escalation studies"
    },
    {
      "code": "HM-2a",
      "display": "Evaluation Form 2a: For therapies that are not likely to be curative with primary endpoint of OS"
    },
    {
      "code": "HM-2b",
      "display": "Evaluation Form 2b: For therapies that are not likely to be curative with primary endpoint PFS"
    },
    {
      "code": "HM-2c",
      "display": "Evaluation Form 2c: For therapies that are not likely to be curative with primary endpoint other than OS or PFS or equivalent (non-inferiority) studies"
    },
    {
      "code": "HM-3",
      "display": "Evaluation Form 3: For single-arm studies in orphan diseases and for diseases with high unmet need when primary outcome is PFS or ORR"
    }
  ]
}